BIOMILQ secures USD21m in Series A financing
North Carolina-based mammary biotechnology company BIOMILQ has successfully closeed USD21 million in Series A financing, which will enable their acceleration of bringing cell-cultured human milk to market. Leading the fundraise are Danish life science investor Novo Holdings and clean tech leader Breakthrough Energy Ventures. Additional support comes from Blue Horizon,